{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:38:03Z","timestamp":1781829483925,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1279,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1038\/jid.2011.483","type":"journal-article","created":{"date-parts":[[2012,2,9]],"date-time":"2012-02-09T11:13:31Z","timestamp":1328786011000},"page":"1583-1590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Tretinoin and the Prevention of Keratinocyte Carcinoma (Basal and Squamous Cell Carcinoma of the Skin): A Veterans Affairs Randomized Chemoprevention Trial"],"prefix":"10.1016","volume":"132","author":[{"given":"Martin A.","family":"Weinstock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen F.","family":"Bingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"DiGiovanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amilcar E.","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Marcolivio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Eilers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Naylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kirsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Kalivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia E.","family":"Vertrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2011.483_bb0010","first-page":"S35","article-title":"Oral prednisone use and risk of keratinocyte carcinoma: the VA topical tretinoin chemoprevention trial","volume":"131","author":"Baibergenova","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.483_bb0015","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1200\/JCO.1995.13.8.1933","article-title":"Prevention of skin-cancer and reduction of keratotic skin-lesions during acitretin therapy in renal-transplant recipients\u2014a double-blind, placebo-controlled study","volume":"13","author":"Bavinck","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1038\/jid.2011.483_bb0020","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/0145-2126(86)90052-4","article-title":"Inefficacy of the synthetic aromatic retinoid etretinate and of its free acid on the in vitro differentiation of leukemic cells","volume":"10","author":"Chomienne","year":"1986","journal-title":"Leukemia Res"},{"key":"10.1038\/jid.2011.483_bb0025","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/1523-1747.ep12365600","article-title":"Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness","volume":"107","author":"Chren","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.483_bb0030","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/jnci\/djn262","article-title":"Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial","volume":"100","author":"Christian","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/jid.2011.483_bb0035","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/cncr.24284","article-title":"Actinic keratoses natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial","volume":"115","author":"Criscione","year":"2009","journal-title":"Cancer"},{"key":"10.1038\/jid.2011.483_bb0040","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0190-9622(08)80258-7","article-title":"Retinoids for the future\u2014oncology","volume":"27","author":"Digiovanna","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2011.483_bb0045","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1016\/S0041-1345(98)00806-9","article-title":"Posttransplantation skin cancer: scope of the problem, management, and role for systemic retinoid chemoprevention","volume":"30","author":"DiGiovanna","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1038\/jid.2011.483_bb0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7326\/0003-4819-150-1-200901060-00004","article-title":"Association between statin use and risk for keratinocyte carcinoma in the veterans affairs topical tretinoin chemoprevention trial","volume":"150","author":"Dore","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1038\/jid.2011.483_bb0055","first-page":"469","article-title":"Formation of gastric carcinoma in albino rats fed on deficient diets","volume":"10","author":"Fujimaki","year":"1926","journal-title":"J Cancer Res"},{"key":"10.1038\/jid.2011.483_bb0060","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1365-2133.2009.09341.x","article-title":"Tolerability of high-dose topical tretinoin: the Veterans Affairs Topical Tretinoin Chemoprevention Trial","volume":"161","author":"Geng","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2011.483_bb0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1440-0960.2002.00613.x","article-title":"Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients","volume":"43","author":"George","year":"2002","journal-title":"Australas J Dermatol"},{"key":"10.1038\/jid.2011.483_bb0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jaad.2007.03.021","article-title":"Reliability of the histopathologic diagnosis of keratinocyte carcinomas","volume":"57","author":"Jagdeo","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2011.483_bb0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/1523-1747.ep12533424","article-title":"Effects of retinoid (Ro 10-9359) on the plasma membrane of keratinocytes in patients with psoriasis: a freeze\u2013fracture analysis","volume":"80","author":"Kitajima","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2011.483_bb0080","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0190-9622(86)70242-9","article-title":"Topical tretinoin for photoaged skin","volume":"15","author":"Kligman","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2011.483_bb0085","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.transproceed.2006.02.119","article-title":"Oral retinoids for chemoprevention of skin cancers in organ transplant recipients: results of a survey","volume":"38","author":"Kovach","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1038\/jid.2011.483_bb0090","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM198806233182501","article-title":"Prevention of skin-cancer in xeroderma pigmentosum with the use of oral isotretinoin","volume":"318","author":"Kraemer","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2011.483_bb0095","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jaad.2010.02.014","article-title":"Prospective quality of life impact of keratinocyte carcinomas Observations from the Veterans Affairs Topical Tretinoin Chemoprevention Trial","volume":"63","author":"Lee","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2011.483_bb0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2340\/00015555-0972","article-title":"Prospective quality of life impact of actinic keratoses: observations from the Veterans Affairs Topical Tretinoin Chemoprevention Trial","volume":"91","author":"Lee","year":"2011","journal-title":"Acta Dermatol Venereol"},{"key":"10.1038\/jid.2011.483_bb0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0003-9861(81)90019-9","article-title":"Membrane effects of retinoids: possible correlation with toxicity","volume":"207","author":"Meeks","year":"1981","journal-title":"Arch Biochem Biophys"},{"key":"10.1038\/jid.2011.483_bb0110","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/pds.2142","article-title":"Association between non-steroidal anti-inflammatory drugs and keratinocyte carcinomas of the skin among participants in the Veterans Affairs Topical Tretinoin Chemoprevention Trial","volume":"20","author":"Nunes","year":"2011","journal-title":"Pharmacoepidemiol Dr S"},{"key":"10.1038\/jid.2011.483_bb0115","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archdermatol.2010.19","article-title":"Incidence estimate of nonmelanoma skin cancer in the United States, 2006","volume":"146","author":"Rogers","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2011.483_bb0120","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1046\/j.1365-2133.2002.49297.x","article-title":"Actinic keratoses in renal transplant recipients do not improve with calcipotriol cream and all-trans retinoic acid cream as monotherapies or in combination during a 6-week treatment period","volume":"147","author":"Smit","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2011.483_bb0125","first-page":"375","article-title":"Clinical and laboratory adverse-effects associated with long-term, low-dose isotretinoin\u2014incidence and risk-factors","volume":"2","author":"Tangrea","year":"1993","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1038\/jid.2011.483_bb0130","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/84.5.328","article-title":"Long-term therapy with low-dose isotretinoin for prevention of basal-cell carcinoma\u2014a Multicenter Clinical-Trial","volume":"84","author":"Tangrea","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/jid.2011.483_bb0135","first-page":"1055","article-title":"Reliability of counting actinic keratoses before and after brief consensus discussion\u2014The VA Topical Tretinoin Chemoprevention (VATTC) Trial","volume":"137","author":"Weinstock","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2011.483_bb0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/archdermatol.2008.542","article-title":"Topical tretinoin therapy and all-cause mortality","volume":"145","author":"Weinstock","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2011.483_bb0145","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jaad.2009.02.022","article-title":"Quality of life in the actinic neoplasia syndrome: the VA Topical Tretinoin Chemoprevention (VATTC) trial","volume":"61","author":"Weinstock","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2011.483_bb0150","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1084\/jem.42.6.753","article-title":"Tissue changes following deprivation of fat-soluble A vitamin","volume":"42","author":"Wolbach","year":"1925","journal-title":"J Exp Med"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1535781X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1535781X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T18:07:25Z","timestamp":1743962845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X1535781X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0022202X1535781X"],"URL":"https:\/\/doi.org\/10.1038\/jid.2011.483","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tretinoin and the Prevention of Keratinocyte Carcinoma (Basal and Squamous Cell Carcinoma of the Skin): A Veterans Affairs Randomized Chemoprevention Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2011.483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}